Mary Agnes Wilderotter - 05 Jan 2024 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Julie Shah, Attorney-in-Fact for Mary Agnes Wilderotter
Issuer symbol
SANA
Transactions as of
05 Jan 2024
Net transactions value
$0
Form type
4
Filing time
08 Jan 2024, 17:38:17 UTC
Previous filing
30 Nov 2023
Next filing
12 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $0 +1,470 +26% $0.000000 7,106 05 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested restricted stock units.